This issue of McDermott’s Healthcare Regulatory Check-Up highlights significant regulatory activity for October 2023. We discuss several enforcement actions that involve violations of the False Claims Act (FCA) and the Anti-Kickback Statute (AKS). We also review recent Office of the Inspector General (OIG) advisory opinions on a proposed employment compensation bonus methodology and provision of free hearing aids to Medicare beneficiaries contingent on the sale of a Medicare-reimbursable cochlear implant.
